About us
ABOUT US
Bavarian Nordic is a fully integrated biotechnology company focused on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases.
READ MORE
Company Overview
Management
Board of Directors

Corporate Governance
Diversity in the Board
Board Committees
Board Evaluation
Remuneration Policy
Articles of Association

Corporate Social Responsibility
What we do
WHAT WE DO
Bavarian Nordic focuses on developing product candidates to address cancer and infectious diseases.
READ MORE
Products
Pipeline
Technology
Manufacturing
Partnering

Infectious Diseases
Smallpox
Monkeypox
RSV
Ebola
Equine encephalitis
HPV
Cancer Immunotherapy
Chordoma

Clinical Trials
Expanded Access Policy
Publications
Posters
INVESTORS
INVESTORS
Bavarian Nordic is committed to providing our shareholders and the media with reliable and transparent information about our business, development programs and results in an open and timely manner
Read more
News
Subscribe
Events & Presentations
Downloads
Financial Reports
CSR Reports
Image Archive

Share Information
Stock Chart
Analysts
Ownership
ADR Program

Shareholder Portal
FAQ
Contact
IR Policy
Careers
CAREERS
Bavarian Nordic offers a challenging international working environment in which
job satisfaction and personal growth have a high priority.
READ MORE
Working With Us
Our Values
Our Employee Philosophy
Our Code of Ethics

Our Employees

The Recruitment Process
Privacy Notice for Applicants
Job Openings
For Students

Media and Investor Relations Contact

Rolf Sass Sørensen

Vice President, Investor Relations and Communications

View lessView more

Bavarian Nordic A/S
Philip Heymans Alle 3
DK-2900 Hellerup
Denmark

Phone: +45 33 26 83 83
E-mail: investor@bavarian-nordic.com

ABOUT US

WHAT WE DO

INVESTORS

CAREERS

Media and Investor Relations Contact

Rolf Sass Sørensen